COVID-19 vaccine hesitancy: Considerations for reluctance and improving vaccine uptake.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
30 11 2022
Historique:
pubmed: 19 4 2022
medline: 7 7 2022
entrez: 18 4 2022
Statut: ppublish

Résumé

The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) pandemic during the fall of 2019 led to the rapid development of vaccines aimed at curbing viral infection, spread, and its potential eradication. A recent trend is an overall increase in vaccine hesitancy, leading to the World Health Organization citing this as a problem which needs to be addressed. With the development and approval of vaccines for COVID-19, this trend has quickened, leading to potential negative ramifications in the ability controlling COVID-19 spread. Here we describe reported examples in overall vaccine hesitancy prior to the emergence of COVID-19, as well as summarizing recent reports on vaccine hesitancy related to COVID-19 vaccines. Gaining a better understanding of the reasons individuals have, as well as potential methods for decreasing hesitancy in the future, will hopefully lead to a greater percentage of vaccinated individuals and aid in ending the current pandemic.

Identifiants

pubmed: 35436173
doi: 10.1080/21645515.2022.2062972
pmc: PMC9897654
doi:

Substances chimiques

COVID-19 Vaccines 0
Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2062972

Références

Postgrad Med J. 2022 Jul;98(1161):539-543
pubmed: 34588293
Hum Vaccin Immunother. 2016 Sep;12(9):2464-8
pubmed: 27159558
J Community Health. 2021 Apr;46(2):270-277
pubmed: 33389421
J Ambul Care Manage. 2021 Jan/Mar;44(1):71-75
pubmed: 33165121
Front Public Health. 2021 Apr 21;9:626852
pubmed: 33968880
Hum Vaccin Immunother. 2014;10(9):2584-96
pubmed: 25483505
Health Psychol. 2018 Apr;37(4):307-315
pubmed: 29389158
Psychol Med. 2022 Oct;52(14):3127-3141
pubmed: 33305716
Health Psychol. 2018 Apr;37(4):316-317
pubmed: 29608075
Hum Vaccin Immunother. 2021 Oct 3;17(10):3355-3364
pubmed: 34187310
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
Indian Pediatr. 2016 Aug 7;53 Suppl 1:S20-S27
pubmed: 27771635
J Public Health (Oxf). 2021 Sep 22;43(3):445-449
pubmed: 33367857
Lancet Public Health. 2021 Jun;6(6):e416-e427
pubmed: 33991482
Ecohealth. 2021 Mar;18(1):44-60
pubmed: 34086129
Vaccines (Basel). 2020 Oct 03;8(4):
pubmed: 33022917
Clin Transl Sci. 2021 Nov;14(6):2200-2207
pubmed: 34213073
Am J Prev Med. 2021 Jan;60(1 Suppl 1):S77-S86
pubmed: 33189502
Jpn J Infect Dis. 2011;64(1):1-6
pubmed: 21266748
Am J Infect Control. 1982 May;10(2):53-9
pubmed: 7044193
Lancet. 2021 Dec 4;398(10316):2093-2100
pubmed: 34756184
Cleve Clin J Med. 2019 Jun;86(6):393-398
pubmed: 31204978
Lancet Infect Dis. 2020 May;20(5):e80-e89
pubmed: 32278359
Vaccines (Basel). 2021 Mar 22;9(3):
pubmed: 33810131
Hum Vaccin Immunother. 2020 Nov 1;16(11):2800-2808
pubmed: 32209009
Hum Vaccin Immunother. 2018 Jul 3;14(7):1599-1609
pubmed: 29617183
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
SSM Popul Health. 2021 Sep;15:100824
pubmed: 34075337
Vaccine. 2017 Oct 9;35(42):5519-5521
pubmed: 28890190
Hum Vaccin Immunother. 2021 Oct 3;17(10):3348-3354
pubmed: 34096836
Vaccine. 2015 Aug 14;33(34):4176-9
pubmed: 25896376
Clin Infect Dis. 2021 Nov 16;73(10):1784-1789
pubmed: 33560346
Nat Hum Behav. 2021 Jul;5(7):947-953
pubmed: 33972767
BMJ. 2002 Aug 24;325(7361):430-2
pubmed: 12193361
Hum Vaccin Immunother. 2013 Dec;9(12):2654-7
pubmed: 24126048
Pediatr Ann. 2015 Apr;44(4):e71-5
pubmed: 25875982
Hum Vaccin Immunother. 2019;15(11):2527-2533
pubmed: 31050594
Soc Sci Med. 2021 Mar;272:113638
pubmed: 33414032
Pediatrics. 2020 Jul;146(1):
pubmed: 32540985
Nurs Womens Health. 2020 Feb;24(1):45-51
pubmed: 31917147
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274
PLoS One. 2021 Aug 24;16(8):e0256122
pubmed: 34428216
Public Health. 2021 May;194:245-251
pubmed: 33965796
Philos Trans R Soc Lond B Biol Sci. 2015 Apr 19;370(1666):
pubmed: 25750241
Lancet Public Health. 2021 Apr;6(4):e210-e221
pubmed: 33556325
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3568-3574
pubmed: 34242848
Vaccine. 2013 Apr 12;31(16):2011-23
pubmed: 23499565

Auteurs

Kaushal Parimi (K)

Thomas Jefferson Independent Day School, Joplin, MO, USA.

Kyle Gilkeson (K)

Department of Basic Sciences, College of Medicine, Kansas City University, Joplin, MO, USA.

Bradley A Creamer (BA)

Department of Basic Sciences, College of Medicine, Kansas City University, Joplin, MO, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH